Addex Therapeutics Ltd. (ADXN) Total Non-Current Liabilities (2022 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Addex Therapeutics' Total Non-Current Liabilities history spans 3 years, with the latest figure at $227093.2 for Q4 2024.

• For Q4 2024, Total Non-Current Liabilities fell 66.6% year-over-year to $227093.2; the TTM value through Dec 2024 reached $227093.2, down 66.6%, while the annual FY2024 figure was $226134.3, 66.33% down from the prior year.
• Total Non-Current Liabilities for Q4 2024 was $227093.2 at Addex Therapeutics, down from $679948.1 in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $679948.1 in Q4 2023 and bottomed at $90337.0 in Q4 2022.
• The 3-year median for Total Non-Current Liabilities is $227093.2 (2024), against an average of $332459.4.
• The largest annual shift saw Total Non-Current Liabilities skyrocketed 652.68% in 2023 before it crashed 66.6% in 2024.
• A 3-year view of Total Non-Current Liabilities shows it stood at $90337.0 in 2022, then surged by 652.68% to $679948.1 in 2023, then plummeted by 66.6% to $227093.2 in 2024.
• Per Business Quant, the three most recent readings for ADXN's Total Non-Current Liabilities are $227093.2 (Q4 2024), $679948.1 (Q4 2023), and $90337.0 (Q4 2022).

Peer Comparison